Company is advancing mitochondriotropic therapeutic pipeline for rare neuromuscular disorders and neurodegenerative diseases Company is advancing mitochondriotropic therapeutic pipeline for rare neuromuscular disorders and neurodegenerative diseases
MitoRx Therapeutics Strengthens Scientific Advisory Board with Appointment of Four International Experts
